Igea gives professionals, patients and investors interested in pharmaceuticals, biotechnology, healthcare technology, diagnostics and medical devices the most relevant, actionable news, information and analysis available anywhere. Our goal is to provide expert insights, analysis and information from industry leaders with a deep understanding of life sciences, medicine and healthcare. Created and curated by Luca Dezzani, MD, Global Medical Director at Novartis Oncology*, Igea offers an insider’s view on the most important developments in life sciences, healthcare technology, digital health and more.

Medicine, healthcare and technology are converging and changing faster than ever before. Throughout the world, the focus on improving the health and the quality of life of all people is driving changes in government policy, public health strategies, access to medicines, the life sciences and healthcare technology industries, and patient advocacy. The most timely and relevant information, analysis and insights into these key areas will help medical professionals, industry executives, researchers and patients better understand these changes and make decisions that can contribute to better health outcomes and quality of life for themselves, their industry and their families. Igea will provide this information.

When you come to igeahub.com, you will find news and updates on critical topics that include, but are not limited to

Pharmaceutical and biologics research and development
Diagnostics and personalized medicine
Access to medicines
Clinical trials
Data analytics
Intellectual property and patent protection
Health policy
Reimbursement
Electronic medical records
Medical devices
Mobile health
Digital health

Igea will also regularly include guest posts from other industry experts. We invite those who are interested in contributing to Igea to please get in touch. Let us know your areas of interest, and please include a short bio or a link to your LinkedIn profile.

We look forward to becoming your trusted partner.